| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B Activation, Leading to Enhanced IFN-
Production in CD4+ T Cells1
* School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea; and
National Creative Research Initiatives Center for Aminoacyl-tRNA Synthetase, College of Pharmacy, Seoul National University, Seoul, Republic of Korea
Recently, we determined that p43, an auxiliary factor of mammalian multiaminoacyl-tRNA synthetases, is secreted, and functions as a novel pleiotropic cytokine. In this study, we have attempted to characterize the effects of p43 on the generation of IL-12 in mouse macrophages. p43 was determined to induce significant IL-12 production from mouse macrophages in a dose-dependent manner. The stimulatory effect of p43 on the activation of IL-12p40 promoter was mapped to a region harboring an NF-
B binding site. The nuclear extracts from the p43-stimulated macrophages exhibited profound NF-B DNA-binding activity, as determined by the EMSA. In addition, the p43-stimulated IL-12 induction and NF-B DNA-binding activity were significantly suppressed by caffeic acid phenethyl ester and BAY11-7082, both inhibitors of NF-B activation, indicating that p43 induced the production of IL-12 in macrophages mainly via the activation of NF-B. Importantly, p43 increased the level of IFN-
production in the Ag-primed lymph node cells, but had no effect on IL-4 levels. The addition of a neutralizing anti-IL-12p40 mAb to the cell cultures resulted in a decrease of the production of p43-enhanced IFN- by the keyhole limpet hemocyanin-primed lymph node cells. Furthermore, coincubation with p43-pretreated macrophages enhanced the production of IFN- by the keyhole limpet hemocyanin-primed CD4+ T cells, thereby indicating that p43 may enhance IFN- expression in CD4+ T cells via the induction of IL-12 production in macrophages. These results indicate that p43 may play an essential role in the development of the Th1 immune responses associated with cancer immunotherapy and protective immunity against intracellular pathogens.
This article has been cited by other articles:
|
|
 |
|
  R. He, M. K. Oyoshi, L. Garibyan, L. Kumar, S. F. Ziegler, and R. S. Geha TSLP acts on infiltrating effector T cells to drive allergic skin inflammation PNAS, August 19, 2008; 105(33): 11875 - 11880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-J. Kim, M. C. Park, S. J. Choi, Y. S. Oh, E.-C. Choi, H. J. Cho, M. H. Kim, S.-H. Kim, D. W. Kim, S. Kim, et al. Determination of Three-dimensional Structure and Residues of the Novel Tumor Suppressor AIMP3/p18 Required for the Interaction with ATM J. Biol. Chem., May 16, 2008; 283(20): 14032 - 14040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kim, S. H. Kim, S. Kim, D. Cho, and T. S. Kim AIMP1/p43 Protein Induces the Maturation of Bone Marrow-Derived Dendritic Cells with T Helper Type 1-Polarizing Ability J. Immunol., March 1, 2008; 180(5): 2894 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Tang, D. Metzger, S. Leeman, and S. Amar LPS-induced TNF-{alpha} factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways PNAS, September 12, 2006; 103(37): 13777 - 13782. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
